Concepedia

P. C. Waldmeier

PC

107

Publications

5K

Citations

41

H-Index

1971

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Basel

P. C. Waldmeier is an author at Novartis (Switzerland) specializing in medicine, neuropharmacology, and neuroscience.

Top concepts

Publications per year

1971–2015

107

Publications

107

Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811

P. C. Waldmeier, J.-J. Feldtrauer, Ting Qian et al. · Molecular Pharmacology · 2002 · 285 citations

Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 and R-(−)-Deprenyl

Eddy A. Kragten, Isabelle Lalande, Kaspar Zimmermann et al. · Journal of Biological Chemistry · 1998 · 208 citations · Full text

Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABA<sub>B(1)</sub>‐deficient mice

Klemens Kaupmann, John F. Cryan, Petrine Wellendorph et al. · European Journal of Neuroscience · 2003 · 184 citations

, , +19

Serotonin-dopamine interactions in the nigrostriatal system

P. C. Waldmeier, A. Delini‐Stula · European Journal of Pharmacology · 1979 · 171 citations

, , +7

Alteration of central alpha2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin

D. J. Dooley, H. Bittiger, Kathleen Hauser et al. · Neuroscience · 1983 · 144 citations

, , +12

Rows per page

1–5 of 107